2014
Jensen IS, Wu C, Bay CB, Cyr PL . Estimating the clinical value of cangrelor in patients undergoing PCI. International Academy of Cardiology, 19th World Congress on Heart Disease, Boston, MA, 2014.
Topics: Health Economics and Outcomes Research (HEOR)
Wu C, Fortier K, Fan WJ, LePensse K, Bay CB, Cyr PL , Jensen IS. A U.S. hospital budget impact model for oritivancin in ABSSSI patients with risk of MRSA infections. ISPOR 16th Annual European Congress, Amsterdam, Netherlands, 2014.
Topics: Health Economics and Outcomes Research (HEOR)
Bay C, Cyr PL , Jensen IS. Estimating the value of cangrelor from eliminating preloading in coronary artery bypass graft (CABG) patients. ISPOR 16th Annual European Congress, Amsterdam, Netherlands, 2014.
Topics: Health Economics and Outcomes Research (HEOR)
2013
Proctor DM, Suh M , Thompson CM, Harris MA. Mode of action evaluation for hexavalent chromium-induced lung cancer. Presented at Society of Toxicology 52nd Annual Meeting, San Antonio, TX, March 2013.
View Abstract
Topics: Hexavalent Chromium
2012
O’Brien TJ, Hao D, Suh M , Proctor D, Thompson CM, Harris MA, Parsons BL, Meyers MB. K-ras codon 12 GGT to GAT mutation is not elevated in the duodenum of mice subchronically exposed to hexavalent chromium in drinking water. Presented at Society of Toxicology 51st Annual Meeting, San Francisco, CA, March 2012.
View Abstract
A Division of